These include the Eagan-based braemar division, manufacturer of cardiac monitoring systems as well as tissue management and fluid extraction equipment; the Chicago-based agility division, a clinical research organization
The trial was fully enrolled in 2007 with 626 patients and compared Gvax immunotherapy to Taxotere (docetaxel) chemotherapy plus prednisone. The company terminated the trial based on the
The collaboration provides the Radiation Therapy Oncology Group (RTOG) access to US Oncology’s significant patient population, making radiation therapy trials more accessible to cancer patients in the community
Since the acquisition, Exiqon has been integrating Oncotech and Exiqon to form ‘one company’ with multiple business divisions. Oncotech represents Exiqon’s diagnostics division and as part of this
The Aaron Klug Building is a 92,000sqft facility containing laboratories. The facility provides MedImmune with capacity to significantly increase the number of candidate drugs that it can develop
The Series C financing complements the company’s Series B financing that was completed earlier in 2008. The Series B was led by private investors. Together, these two financings
The scope of the project is estimated to be as much as E29 million. The framework agreement follows the three existing iMDsoft installations in hospitals in the region,
In addition to core hemodynamic parameters including cardiac output, cardiac index and stroke volume, the Reliant 2.0 adds new parameters to provide a comprehensive suite of information for
Dr New was co-founder and CEO of Abrika Pharmaceuticals, a specialty pharma company focused on the development of controlled-release generic drugs. Before that, Dr New worked for over
This study of the new tuberculosis (TB) vaccine candidate in Kenya will be conducted by the Walter Reed Project-Kenya (WRP) at Kombewa, near Kisumu, western Kenya. The main
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.